Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRN125 for Stem Cell Mobilization in Multiple Myeloma and Malignant Lymphoma
NCT05007652Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Sep 2021
- Primary completion
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegfilgrastim in multiple myeloma (MM), malignant lymphoma, sponsored by Kyowa Kirin. Started Sep 2021; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
multiple myeloma (MM)malignant lymphoma
Beyond the preview
Go deeper on NCT05007652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05007652.